Clinical Trial Update: SERETIDE Vs FLIXOTIDE In Mild Persistent Asthma (GINAII) [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Seretide to Flixotide in mild persistent asthma (GINA II) completed; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• FLIXOTIDE (Fluticasone Propionate)
• Seretide (fluticasone propionate/salmeterol)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 4 | Status: COMPLETED | Results posted: 2018-01-04